Reviews Of Anti‐infective Agents: Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis-Reference-Cited by-同舟云学术

Reviews Of Anti‐infective Agents: Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis

Published:2006-10 Issue:7 Volume:43 Page:917-924
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:CLIN INFECT DIS

Author:

Bern Caryn,Adler‐Moore Jill,Berenguer Juan,Boelaert Marleen,Boer Margriet den,Davidson Robert N.,Figueras Concepcion,Gradoni Luigi,Kafetzis Dimitris A.,Ritmeijer Koert,Rosenthal Eric,Royce Catherine,Russo Rosario,Sundar Shyam,Alvar Jorge

Publisher

Oxford University Press (OUP)

Link

http://academic.oup.com/cid/article-pdf/43/7/917/1057464/43-7-917.pdf

Reference43 articles.

1. World Health Organization. Leishmaniasis disease burden. Available at: http://www.who.int/leishmaniasis/burden/en/. Accessed 27 April 2005.

2. Risk Factors for Kala-Azar in Bangladesh

3. Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian Epidemic

Cited by 309 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Tetraene Macrodiolides Are Effective Inducers of Mitochondrial Apoptosis in Jurkat Cells;International Journal of Molecular Sciences;2025-05-27

2. Preferred Therapy for Specific Parasitic Pathogens;2025 Nelson’s Pediatric Antimicrobial Therapy;2025-05-01

3. Current state of the art of gold complexes as antileishmanial agents;Coordination Chemistry Reviews;2025-04

4. Anti-leishmanial therapies: overcoming current challenges with emerging therapies;Expert Review of Anti-infective Therapy;2025-03-24

5. First documented case of visceral leishmaniasis with rare colonic involvement in an immunocompetent adult in Slovakia;BMC Infectious Diseases;2025-02-19